Congress Has 100 Days to Act

The medical device tax will go back into effect at the end of this year.

As the clock has continued to tick, we have heard voices across the country speak out against this tax.

We’ve heard from patient leaders like Tracey Dedering, who hope that lawmakers get rid of this tax so cancer “thrivers” can get the treatments they need. We’ve heard from medical professionals, like the American Dental Association, who are worried about the effects of device tax on patient care, innovation and cost. We’ve heard from members of the media, including the Wall Street Journal editorial board, who recognize that the device tax is a “nasty tax on medical innovation.” And we’ve heard from bipartisan lawmakers – nearly 300 of them! – who agree that it is time to fully repeal this tax once and for all.

So today as we begin the 100-day countdown, we as advocates – and all the voices who have joined us over the past year – must recommit ourselves to the fight for medical innovation. The efforts we have seen from our lawmakers, while important, will only be able to protect jobs and medical innovation if legislation is passed by December 31st.

Make sure your lawmakers understand the urgent need for action: send your letter now.

Click here to take action.

More Articles

Focused Ultrasound Advocates Visit Capitol Hill

June 26, 2023

Recently, the Medical Imaging & Technology Alliance (MITA) joined with the Focused Ultrasound Foundation to host a group…

Read More

This National Minority Health Month, Support the FIND Act to Expand Access to Innovative Diagnostics

April 4, 2023

Bipartisan Bill Would Help Address Disparities in Alzheimer’s and Parkinson’s Disease, Breast and Prostate Cancer Recognized every year…

Read More

Advocates Across the Country Speak Out Against Medicare Cuts

October 18, 2022

These pandemic years have been challenging, especially for doctors, who have worked to adapt, treat, and lead us…

Read More

How Focused Ultrasound Helped One Patient Treat His Prostate Cancer

July 28, 2022

When Michael Swann turned 60, his urologist explained the importance of monitoring prostate-specific antigen (PSA) levels as an…

Read More